Hyndland Partners’ healthcare team is trusted to lead industry-defining transactions.
We have coverage across healthcare, life sciences, and biotechnology in product, services, and R&D categories.
From advising global pharmaceutical giants to running competitive sales processes for regional market leaders, we are a dynamic team with coverage across the Americas, Europe, Asia, and Oceania. We have relationships with industry executives, policymakers, and investors who shape outcomes, enabling us to advise with clarity and precision.
Our team has advised on public-to-private transactions, represented three Fortune 100 healthcare companies, and is continually called upon to lead high-profile mandates. Clients rely on us for discretion, judgment, and proven capability in executing transactions that shape the global healthcare landscape.